Arzneimittelprüfung von Cyclosporinum

Author(s): Y. J. , E., T. , I., J. , L., K. , N., A. , R., B. O. , R., H. , S., D. , T.

Journal/Book: Allgemeine Homöopathische Zeitung. 1995; 240/1: 3-10.

Abstract: Cyclosporinum represents a major medical advancement in immunosupression and organ transplantation through suppression of the "helper T-cells" (CD 4). The Norwegian Academy for Natural Medicine did 1991-1993 a proving of Cyclosporium D12-200. The main characteristics of the remedy are weakness, coldness, dryness and symptoms from the distestive and urinary systems. The remedy will be clinically tested by a group of experienced homoeopaths during 1994 for immunological properties.

Keyword(s): Arzneimittelprüfung von Cyclosporidium D12-200, Immunmodulierung

Zurück | Weiter